RxDoctor Payments Data

Daniel Williams

Medical Oncology · Lewiston, IDNPI 1508809252

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.7% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,074 and has fallen 97.7% since, to $24 in 2022.

$1,352in general payments, 2019–2025

Across 67 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$169
  • Rigel Pharmaceuticals, Inc.$157
  • AstraZeneca$144
  • Novartis$126
  • Seagen Inc.$125
  • Merck$90
  • plus $541 from 18 others

What the payments were for

  • Food & beverage$1,23992%
  • Education$1128%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few medical oncology providers in Idahoto place this figure against a meaningful peer group, so we don't.

Other medical oncology in Lewiston

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →